{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T21:47:24Z","timestamp":1767908844625,"version":"3.49.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T00:00:00Z","timestamp":1595030400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biophys Rev"],"published-print":{"date-parts":[[2020,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Renal transplant is a lifesaving and cost-effective intervention for patients with End Stage Renal Failure. Yet it is often regarded as replacement therapy rather than a cure given the overall failure rate over time. With a shortage of organs, this global issue has been further compounded by increased incidences of obesity, hypertension and diabetes, such that the disease burden and need for transplantation continues to increase. Considering the lifetime of immunosupression in transplant patients, there will also be significant associated co-morbidities By leveraging the advances in innovation in Next Generation Sequencing, the field of transplant can now monitor patients with an optimized surveillance schedule, and change the care paradigm in the post-transplant landscape. Notably, low grade inflammation is an independent risk for mortality across different disease states. In transplantation, sub-clinical inflammation enhances acute and chronic rejection, as well as accelerates pathologies that leads to graft loss. Cell\u00a0free DNA has been shown to be increased in inflammatory processes as we all as provide an independent predictor of all-cause mortality. This review considers the utility of AlloSure, a donor derived cell free DNA molecular surveillance tool, which has shown new clinical insights on how best to manage renal transplant patients, and how to improve patient outcomes.<\/jats:p>","DOI":"10.1007\/s12551-020-00713-5","type":"journal-article","created":{"date-parts":[[2020,7,18]],"date-time":"2020-07-18T05:19:10Z","timestamp":1595049550000},"page":"917-924","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Understanding and using AlloSure donor\u00a0derived cell-free DNA"],"prefix":"10.1007","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0196-5459","authenticated-orcid":false,"given":"R. K.","family":"Seeto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9686-3107","authenticated-orcid":false,"given":"J. N.","family":"Fleming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5788-4420","authenticated-orcid":false,"given":"S.","family":"Dholakia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4984-5517","authenticated-orcid":false,"given":"B. L.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,18]]},"reference":[{"key":"713_CR1","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.2215\/CJN.00930209","volume":"4","author":"S Abedini","year":"2009","unstructured":"Abedini S, Holme I, Marz W et al (2009) Inflammation in renal transplantation. Clin J Am Soc Nephrol 4:1246\u20131254","journal-title":"Clin J Am Soc Nephrol"},{"key":"713_CR2","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.healun.2018.01.1305","volume":"37","author":"S Agbor-Enoh","year":"2018","unstructured":"Agbor-Enoh S, Jackson AM, Tunc I et al (2018) Late manifestation of alloantibody-associated injury and clinical pulmonary antibody-mediated rejection: evidence from cell-free DNA analysis. J Heart Lung Transplant 37:925\u2013932","journal-title":"J Heart Lung Transplant"},{"key":"713_CR3","unstructured":"Alhamad T, Poggio E, Hiller D, Dholakia S, Sood P (2019) The use of dd-cfDNA as a predictive tool for outcome decreased kidney function [abstract]. Am J Transplant;19 (suppl 3)"},{"key":"713_CR4","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1681\/ASN.2016091034","volume":"28","author":"RD Bloom","year":"2017","unstructured":"Bloom RD, Bromberg JS, Poggio ED et al (2017) Cell-free DNA and active rejection in kidney allografts. J Am Soc Nephrol 28:2221\u20132232","journal-title":"J Am Soc Nephrol"},{"key":"713_CR5","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.3324\/haematol.2016.144055","volume":"101","author":"M Bonaccio","year":"2016","unstructured":"Bonaccio M, Di Castelnuovo A, Pounis G et al (2016) A score of low-grade inflammation and risk of mortality: prospective findings from the Moli-sani study. Haematologica 101:1434\u20131441","journal-title":"Haematologica"},{"key":"713_CR6","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1038\/nrneph.2016.41","volume":"12","author":"F Braza","year":"2016","unstructured":"Braza F, Brouard S, Chadban S, Goldstein DR (2016) Role of TLRs and DAMPs in allograft inflammation and transplant outcomes. Nat Rev Nephrol 12:281\u2013290","journal-title":"Nat Rev Nephrol"},{"key":"713_CR7","unstructured":"Brennan D, Bromberg J, Yee J, Dholakia S, Haas M (2019) Donor derived cell free DNA (dd-cfDNA) may aid in the diagnosis of BK virus nephropathy [abstract]. Am J Transplant;19 (suppl 3)"},{"key":"713_CR8","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1373\/jalm.2016.022731","volume":"2","author":"JS Bromberg","year":"2017","unstructured":"Bromberg JS, Brennan DC, Poggio E et al (2017) Biological variation of donor-derived cell-free DNA in renal transplant recipients: clinical implications. J Appl Lab Med 2:309\u2013321","journal-title":"J Appl Lab Med"},{"key":"713_CR9","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/j.humimm.2011.07.001","volume":"72","author":"G Chen","year":"2011","unstructured":"Chen G, Sequeira F, Tyan DB (2011) Novel C1q assay reveals a clinically relevant subset of human leukocyte antigen antibodies independent of immunoglobulin G strength on single antigen beads. Hum Immunol 72:849\u2013858","journal-title":"Hum Immunol"},{"key":"713_CR10","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1681\/ASN.2015050524","volume":"27","author":"PA Clayton","year":"2016","unstructured":"Clayton PA, Lim WH, Wong G, Chadban SJ (2016) Relationship between eGFR decline and hard outcomes after kidney transplants. J Am Soc Nephrol 27:3440\u20133446","journal-title":"J Am Soc Nephrol"},{"key":"713_CR11","doi-asserted-by":"publisher","first-page":"3756","DOI":"10.1093\/ndt\/gfr163","volume":"26","author":"DO Dahle","year":"2011","unstructured":"Dahle DO, Mjoen G, Oqvist B et al (2011) Inflammation-associated graft loss in renal transplant recipients. Nephrol Dial Transplant 26:3756\u20133761","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"713_CR12","doi-asserted-by":"publisher","first-page":"100542","DOI":"10.1016\/j.trre.2020.100542","volume":"34","author":"F Dengu","year":"2020","unstructured":"Dengu F (2020) Next-generation sequencing methods to detect donor-derived cell-free DNA after transplantation. Transplant Rev (Orlando) 34(3):100542","journal-title":"Transplant Rev (Orlando)"},{"key":"713_CR13","doi-asserted-by":"crossref","unstructured":"Dholakia S, De Vlaminck I, Khush KK (2020) Adding insult on injury: immunogenic role for donor-derived cell-free DNA? Transplantation","DOI":"10.1097\/TP.0000000000003240"},{"key":"713_CR14","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1097\/TP.0b013e31827d62e3","volume":"95","author":"MJ Everly","year":"2013","unstructured":"Everly MJ, Rebellato LM, Haisch CE et al (2013) Incidence and impact of de novo donor-specific alloantibody in primary renal allografts. Transplantation 95:410\u2013417","journal-title":"Transplantation"},{"key":"713_CR15","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1097\/TP.0000000000002026","volume":"102","author":"G Faddoul","year":"2018","unstructured":"Faddoul G, Nadkarni GN, Bridges ND et al (2018) Analysis of biomarkers within the initial 2 years posttransplant and 5-year kidney transplant outcomes: results from clinical trials in organ transplantation-17. Transplantation 102:673\u2013680","journal-title":"Transplantation"},{"key":"713_CR16","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/ajt.14625","volume":"18","author":"M Haas","year":"2018","unstructured":"Haas M, Loupy A, Lefaucheur C et al (2018) The Banff 2017 kidney meeting report: revised diagnostic criteria for chronic active T cell-mediated rejection, antibody-mediated rejection, and prospects for integrative endpoints for next-generation clinical trials. Am J Transplant 18:293\u2013307","journal-title":"Am J Transplant"},{"key":"713_CR17","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1097\/01.TP.0000156165.83160.09","volume":"79","author":"HH Hirsch","year":"2005","unstructured":"Hirsch HH, Brennan DC, Drachenberg CB et al (2005) Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 79:1277\u20131286","journal-title":"Transplantation"},{"key":"713_CR18","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/ajt.15289","volume":"19","author":"E Huang","year":"2019","unstructured":"Huang E, Sethi S, Peng A et al (2019) Early clinical experience using donor-derived cell-free DNA to detect rejection in kidney transplant recipients. Am J Transplant 19:1663\u20131670","journal-title":"Am J Transplant"},{"key":"713_CR19","doi-asserted-by":"publisher","first-page":"e379","DOI":"10.1097\/TXD.0000000000000821","volume":"4","author":"SC Jordan","year":"2018","unstructured":"Jordan SC, Bunnapradist S, Bromberg JS et al (2018) Donor-derived cell-free DNA identifies antibody-mediated rejection in donor specific antibody positive kidney transplant recipients. Transplant Direct 4:e379","journal-title":"Transplant Direct"},{"key":"713_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1097\/TP.0000000000002482","volume":"103","author":"SR Knight","year":"2019","unstructured":"Knight SR, Thorne A, Lo Faro ML (2019) Donor-specific cell-free DNA as a biomarker in solid organ transplantation. A systematic review. Transplantation 103:273\u2013283","journal-title":"Transplantation"},{"key":"713_CR21","doi-asserted-by":"crossref","unstructured":"Kobashigawa JAPJ, Kransdorf E et al (2019) Does cell-free DNA detect the development of De novo donor specific antibodies. J Heart Lung Transplant 38","DOI":"10.1016\/j.healun.2019.01.723"},{"key":"713_CR22","doi-asserted-by":"publisher","first-page":"2152","DOI":"10.1097\/TP.0000000000001548","volume":"101","author":"MZ Molnar","year":"2017","unstructured":"Molnar MZ, Nagy K, Remport A et al (2017) Inflammatory markers and outcomes in kidney transplant recipients. Transplantation 101:2152\u20132164","journal-title":"Transplantation"},{"key":"713_CR23","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1007\/s12325-016-0292-y","volume":"33","author":"G Muduma","year":"2016","unstructured":"Muduma G, Odeyemi I, Smith-Palmer J, Pollock RF (2016) Review of the clinical and economic burden of antibody-mediated rejection in renal transplant recipients. Adv Ther 33:345\u2013356","journal-title":"Adv Ther"},{"key":"713_CR24","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1111\/ajt.15197","volume":"19","author":"BJ Nankivell","year":"2019","unstructured":"Nankivell BJ, Agrawal N, Sharma A et al (2019) The clinical and pathological significance of borderline T cell-mediated rejection. Am J Transplant 19:1452\u20131463","journal-title":"Am J Transplant"},{"key":"713_CR25","first-page":"103","volume":"32","author":"SJ Patel","year":"2016","unstructured":"Patel SJ, Kuten SA, Knight RJ, Graviss EA, Nguyen D, Gaber AO (2016) Incidence and factors associated with de novo DSA after BK viremia in renal transplant recipients. Clin Transpl 32:103\u2013109","journal-title":"Clin Transpl"},{"key":"713_CR26","doi-asserted-by":"publisher","first-page":"e385","DOI":"10.1097\/TXD.0000000000000823","volume":"4","author":"RVG Ponsirenas","year":"2018","unstructured":"Ponsirenas RVG, Cazarote HB, Araujo SA et al (2018) Anti-HLA donor-specific IgG subclasses and C1q-binding evolution in posttransplant monitoring. Transplant Direct 4:e385","journal-title":"Transplant Direct"},{"key":"713_CR27","doi-asserted-by":"publisher","first-page":"e0116206","DOI":"10.1371\/journal.pone.0116206","volume":"10","author":"MJ Proctor","year":"2015","unstructured":"Proctor MJ, McMillan DC, Horgan PG, Fletcher CD, Talwar D, Morrison DS (2015) Systemic inflammation predicts all-cause mortality: a Glasgow inflammation outcome study. PLoS One 10:e0116206","journal-title":"PLoS One"},{"key":"713_CR28","first-page":"78","volume":"8","author":"F Reyna-Sepulveda","year":"2017","unstructured":"Reyna-Sepulveda F, Ponce-Escobedo A, Guevara-Charles A et al (2017) Outcomes and surgical complications in kidney transplantation. Int J Organ Transplant Med 8:78\u201384","journal-title":"Int J Organ Transplant Med"},{"key":"713_CR29","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1681\/ASN.2014010119","volume":"26","author":"D Sawinski","year":"2015","unstructured":"Sawinski D, Forde KA, Trofe-Clark J et al (2015) Persistent BK viremia does not increase intermediate-term graft loss but is associated with de novo donor-specific antibodies. J Am Soc Nephrol 26:966\u2013975","journal-title":"J Am Soc Nephrol"},{"key":"713_CR30","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.jim.2018.09.011","volume":"463","author":"K Sherwood","year":"2018","unstructured":"Sherwood K, Weimer ET (2018) Characteristics, properties, and potential applications of circulating cell-free dna in clinical diagnostics: a focus on transplantation. J Immunol Methods 463:27\u201338","journal-title":"J Immunol Methods"},{"key":"713_CR31","doi-asserted-by":"crossref","unstructured":"Sigdel TK, Archila FA, Constantin T, et al. (2018) Optimizing detection of kidney transplant injury by assessment of donor-derived cell-free DNA via massively multiplex PCR. J Clin Med;8","DOI":"10.3390\/jcm8010019"},{"key":"713_CR32","doi-asserted-by":"crossref","unstructured":"Stites E, Kumar D, Olaitan O, et al. (2020) High levels of dd-cfDNA identify patients with TCMR 1A and borderline allograft rejection at elevated risk of graft injury. Am J Transplant","DOI":"10.1111\/ajt.15822"},{"key":"713_CR33","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1111\/ajt.15750","volume":"20","author":"J Sussell","year":"2020","unstructured":"Sussell J, Silverstein AR, Goutam P et al (2020) The economic burden of kidney graft failure in the United States. Am J Transplant 20:1323\u20131333","journal-title":"Am J Transplant"},{"key":"713_CR34","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1097\/TP.0b013e3182483713","volume":"93","author":"PI Terasaki","year":"2012","unstructured":"Terasaki PI (2012) A personal perspective: 100-year history of the humoral theory of transplantation. Transplantation 93:751\u2013756","journal-title":"Transplantation"},{"key":"713_CR35","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.coi.2005.07.018","volume":"17","author":"PI Terasaki","year":"2005","unstructured":"Terasaki PI, Cai J (2005) Humoral theory of transplantation: further evidence. Curr Opin Immunol 17:541\u2013545","journal-title":"Curr Opin Immunol"},{"key":"713_CR36","doi-asserted-by":"crossref","unstructured":"Thongprayoon CVP, Craici IM, Leeaphorn N et al (2020) The use of donor derived cell free DNA for assessment for allograft rejection and injury status. J Clin Med 9","DOI":"10.3390\/jcm9051480"},{"key":"713_CR37","first-page":"750602","volume":"2014","author":"IB Torres","year":"2014","unstructured":"Torres IB, Moreso F, Sarro E, Meseguer A, Seron D (2014) The interplay between inflammation and fibrosis in kidney transplantation. Biomed Res Int 2014:750602","journal-title":"Biomed Res Int"},{"key":"713_CR38","doi-asserted-by":"publisher","first-page":"3929","DOI":"10.1093\/ndt\/gfs255","volume":"27","author":"D Tovbin","year":"2012","unstructured":"Tovbin D, Novack V, Wiessman MP, Abd Elkadir A, Zlotnik M, Douvdevani A (2012) Circulating cell-free DNA in hemodialysis patients predicts mortality. Nephrol Dial Transplant 27:3929\u20133935","journal-title":"Nephrol Dial Transplant"},{"key":"713_CR39","doi-asserted-by":"publisher","first-page":"S14","DOI":"10.1097\/TP.0b013e3181a079c0","volume":"87","author":"MR Weir","year":"2009","unstructured":"Weir MR, Wali RK (2009) Minimizing the risk of chronic allograft nephropathy. Transplantation 87:S14\u2013S18","journal-title":"Transplantation"},{"key":"713_CR40","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/TP.0b013e3182543950","volume":"94","author":"M Willicombe","year":"2012","unstructured":"Willicombe M, Brookes P, Sergeant R et al (2012) De novo DQ donor-specific antibodies are associated with a significant risk of antibody-mediated rejection and transplant glomerulopathy. Transplantation 94:172\u2013177","journal-title":"Transplantation"},{"key":"713_CR41","doi-asserted-by":"publisher","first-page":"182","DOI":"10.2215\/CJN.00700117","volume":"13","author":"R Zhang","year":"2018","unstructured":"Zhang R (2018) Donor-specific antibodies in kidney transplant recipients. Clin J Am Soc Nephrol 13:182\u2013192","journal-title":"Clin J Am Soc Nephrol"}],"updated-by":[{"DOI":"10.1007\/s12551-020-00763-9","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}}],"container-title":["Biophysical Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-020-00713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12551-020-00713-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12551-020-00713-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,17]],"date-time":"2021-07-17T23:53:36Z","timestamp":1626566016000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12551-020-00713-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,18]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["713"],"URL":"https:\/\/doi.org\/10.1007\/s12551-020-00713-5","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s12551-020-00763-9","asserted-by":"object"}]},"ISSN":["1867-2450","1867-2469"],"issn-type":[{"value":"1867-2450","type":"print"},{"value":"1867-2469","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,18]]},"assertion":[{"value":"26 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2020","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"An erratum to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s12551-020-00763-9","URL":"https:\/\/doi.org\/10.1007\/s12551-020-00763-9","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":".","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}}]}}